Bentham Science Logo
Journal Cover

Track Your Manuscript:


Current Psychopharmacology

Volume 10, 3 Issues, 2021
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access

Aims & Scope

Current Psychopharmacology publishes peer-reviewed expert full-length/mini reviews, original research articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology.

Current Psychopharmacology

,

Volume 10

-

Number 1





Biography   Open Access





Review Article

Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-age Youth

, 10(1): 5 - 16

Lisa Domenico, Christina E. DeRemer, Kathy L. Nichols, Christopher Campbell, Jacquelyn R. Moreau, Gail S. Childs and Lisa J. Merlo*


DOI: 10.2174/2211556009999200613224100






Review Article

ADHD in College Students - a Guide for Clinicians and Administrators

, 10(1): 34 - 46

Aaron Winkler*, Bettina Bohle-Frankel, Leigh White, Gordon Strauss and Diane Gottlieb


DOI: 10.2174/2211556009999200616132427


Review Article

Early Psychosis: Diagnosis and Treatment

, 10(1): 47 - 56

Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*


DOI: 10.2174/2211556009999200723123322


Articles Ahead of Print

Endorphinergic Enhancement Attenuation of Post-Traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic


Kenneth Blum*, Edward J. Modestino, David Baron, Raymond Brewer, P. K. Thanos, Igor Elman, Rajendra D. Badgaiyan, B. William Downs, Debasis Bagchi, Thomas McLaughlin, Abdalla Bowirrat, A. Kenison Roy and Mark S. Gold


DOI: 10.2174/2211556009999210104221215
View Abstract




Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise


Bernard W. Downs*, Steve Kushner, Manashi Bagchi, Kenneth Blum, Rajendra D. Badgaiyan and Debasis Bagchi


DOI: 10.2174/2211556010666210122145526
View Abstract



The Role of Folate-Supplementation in Depression: A Narrative Review


Falade Joshua*, Onaolapo Adejoke Yetunde and Onaolapo Olakunle James


DOI: 10.2174/2211556009666201207233954
View Abstract




Abstracts Ahead of Print

Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development


Kenneth Blum*, Abdalla Bowirrat , Marjorie C. Gondre Lewis, Thomas A. Simpatico , Mauro Ceccanti, Bruce Steinberg, Edward J Modestino, Panayotis K Thanos , David Baron, Thomas McLaughlin , Raymond Brewer, Rajendra D. Badgaiyan, Jessica Valdez Ponce, Lisa Lott and Mark S Gold


DOI: 10.2174/2211556010666210215155509
View Abstract


Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling


Kenneth Blum*, Thomas McLaughlin, Edward J. Modestino, David Baron, Abdalla Bowirrat, Raymond Brewer , Bruce Steinberg, A. Kenison Roy, Marcello Febo, Rajendra D. Badgaiyan and Marks S. Gold


DOI: 10.2174/2211556010666210215153513
View Abstract


Dopaminylation in Psychostimulant use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression


Kenneth Blum*, Mark S Gold, Jean L. Cadet, David Baron, Abdalla Bowirrat, Panayotis K. Thanos, Raymond Brewer, Rajendra D. Badgaiyan and Marjorie C. Gondré–Lewis


DOI: 10.2174/2211556009666210108112737
View Abstract


Editor's Choice

Early Psychosis: Diagnosis and Treatment

, 2021; 10(1): 47 - 56

Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*


DOI: 10.2174/2211556009999200723123322




Role of Neurochemicals in Schizophrenia

, 2020; 9(2): 144 - 161

Sher Singh, Deepa Khanna* and Sanjeev Kalra


DOI: 10.2174/2211556009666200401150756



In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing

, 2020; 9(1): 7 - 21

Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan


DOI: 10.2174/2211556008666191111103152



Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action

, 2019; 8(2): 99 - 112

Kenneth Blum*, Todd C. Pappas, Bryan Clifton, David Baron, Margaret A. Madigan, Lisa Lott, Mark Moran, Cannon Clifton, Scott Worrich, Ervey Clarke, Brent Boyett, Abdalla Bowirrat and Mark S. Gold


DOI: 10.2174/2211556008666190827150018




Mechanistic Description of Natural Herbs in the Treatment of Dementia: A Systematic Review

, 2018; 7(2): 149 - 164

Bapi Gorain*, Hira Choudhury, Manisha Pandey, Hasbi Laili Bt Mohd Zaki, Nuurul Izzati Bt Bakar, Nur Hanis Bt Hamdhan, Nor Aniza Bt Musa, Nurul Fadhilah Bt Mustafa, Jaya Sree Sangkari, Nur Ain Athirah Bt Azmi, Lui Park Yeang and Prashant Kesharwani


DOI: 10.2174/2211556007666180420124544






Open Access Articles




Role of Neurochemicals in Schizophrenia

, 2020; 9(2): 144 - 161

Sher Singh, Deepa Khanna* and Sanjeev Kalra




In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing

, 2020; 9(1): 7 - 21

Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan





Sudden Death Associated with Complex Treatment of Acute Mania: Case Report and Toxicological Findings

, 2019; 8(3): 238 - 243

Martina Curto*, Luana Lionetto, Maria Chiara David, Aniello Maiese, Stefano Ferracuti, Maurizio Simmaco and Ross J. Baldessarini





Neuroleptic Malignant Syndrome: A Pilot Study on Psychiatric Inpatients in Iran

, 2019; 8(3): 207 - 212

Saeed S. Shafti*, Alireza Memarie, Masomeh Rezaie and Masomeh Hamidi




Psychotropic Medication Use among Traumatized Individuals with and without Psychiatric Histories

, 2019; 8(3): 194 - 206

Alan R. King*, Sara K. Kuhn, Stephanie Brezinski, Michael Jowkar and Kourtney Smith




An Insight on the Association of Psychological Studies, Cognitive Sciences and Meditation in Treating Depression

, 2019; 8(3): 177 - 193

Rashmi S. Pal*, Nikita Saraswat, Pranay Wal, Ankita Wal, Yogendra Pal and Tamsheel F. Roohi





Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action

, 2019; 8(2): 99 - 112

Kenneth Blum*, Todd C. Pappas, Bryan Clifton, David Baron, Margaret A. Madigan, Lisa Lott, Mark Moran, Cannon Clifton, Scott Worrich, Ervey Clarke, Brent Boyett, Abdalla Bowirrat and Mark S. Gold




Neurosteroids and Affective Disorders in Women

, 2019; 8(2): 89 - 98

Rodrigo Guiza-Zayas*, Mónica Flores-Ramos, Norma Bernal-Santamaría, María Fernanda Del-Pino Mijares and Marián Serna-García




Sertraline Associated with REM Sleep Behavior Disorder: A Case Report

, 2019; 8(2): 159 - 162

Seyed Mostafa Mansouripour * and Dharmendra Kumar





Most Cited Articles






Zebrafish as an Animal Model to Study Epileptic Seizures and Epileptic Syndromes

, 2016; 5(2): 194-210.

Ben H.M. Mussulini, Suelen Baggio, Luana Moro, Renato D. Dias, Maria E. Calcagnotto, Eduardo P. Rico and Diogo L. de Oliveira


DOI: 10.2174/2211556005666160615090734




Most Accessed Articles

ADHD in College Students - a Guide for Clinicians and Administrators

, 2021; 10(1): 34-46.

Aaron Winkler*, Bettina Bohle-Frankel, Leigh White, Gordon Strauss and Diane Gottlieb


DOI: 10.2174/2211556009999200616132427


Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-age Youth

, 2021; 10(1): 5-16.

Lisa Domenico, Christina E. DeRemer, Kathy L. Nichols, Christopher Campbell, Jacquelyn R. Moreau, Gail S. Childs and Lisa J. Merlo*


DOI: 10.2174/2211556009999200613224100







Early Psychosis: Diagnosis and Treatment

, 2021; 10(1): 47-56.

Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*


DOI: 10.2174/2211556009999200723123322


Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia

, 2020; 9(3): 164-184.

Raymond Brewer, Kenneth Blum*, Abdalla Bowirrat, Edward J. Modestino, David Baron, Rajendra D. Badgaiyan, Mark Moran, Brent Boyett and Mark S. Gold


DOI: 10.2174/2211556009999200628093231





The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum are Reversed by Offspring Deprivation

, 2021; 10(1): 73-83.

Maria C. Mostallino*, Pietro P. Secci, Elena Paci, Maria L. Mura, Elisabetta Maciocco, Enrico Sanna and Giovanni Biggio


DOI: 10.2174/2211556009999200819102313


A Study of Metabolic Syndrome in Patients on Risperidone

, 2020; 9(3): 218-227.

Ajay Thangraj, Nimesh G. Desai and Vijender Singh*


DOI: 10.2174/2211556009666200316143613




Editor-in-Chief

graphic
Kenneth Blum
Western University of Health Sciences
Pomona, CA
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog